Lymphoma Disease Committee of TCOG Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
1995
NCT00262210
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1995

Timeline

NOW
  • Now